Hemostatic alterations associated with supraceliac aortic cross-clamping Petros V. Anagnostopoulos, MD, Alexander D. Shepard, MD, Iraklis I. Pipinos, MD, Sundara B.K. Raman, MD, Pervaiz A. Chaudhry, MD, Takayuki Mishima, MD, Hideaki Morita, MD, George Suzuki, MD Journal of Vascular Surgery Volume 35, Issue 1, Pages 100-108 (January 2002) DOI: 10.1067/mva.2002.118088 Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 1 Time points for blood sampling. Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 2 Platelet (PLT ) count in the supraceliac (SC ) and infrarenal (IR ) aortic cross-clamping (AXC ) groups. PLT count was corrected for dilution with the hematocrit (Hct ). Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 3 Fibrinogen (FBG ) levels in the supraceliac (SC ) and infrarenal (IR ) aortic cross-clamping (AXC ) groups. FBG was corrected for dilution with the hematocrit (Hct ). Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 4 Thrombin-antithrombin complexes (TAT ) in the supraceliac (SC ) and infrarenal (IR ) aortic cross-clamping (AXC ) groups. Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 5 Tissue plasminogen activator (t-PA ) activity (Act ) in the supraceliac (SC ) and infrarenal (IR ) aortic cross-clamping (AXC ) groups. Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 6 Tissue plasminogen activator (t-PA ) antigen (Ag ) in the supraceliac (SC ) and infrarenal (IR ) aortic cross-clamping (AXC ) groups. Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 7 Hepatic vein plasminogen activator inhibitor (PAI-1 ) activity (Act ) in the supraceliac (SC ) aortic cross-clamping (AXC ) groups. Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 8 Plasminogen activator inhibitor (PAI-1 ) activity (Act ) in the supraceliac (SC ) and infrarenal (IR ) aortic cross-clamping (AXC ) groups. Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions
Fig. 9 α 2 antiplasmin (a2-AP ) activity in the supraceliac (SC ) and infrarenal (IR ) aortic cross-clamping (AXC ) groups. Journal of Vascular Surgery 2002 35, 100-108DOI: (10.1067/mva.2002.118088) Copyright © 2002 Society for Vascular Surgery and The American Association for Vascular Surgery Terms and Conditions